Legacy portfolio transition from Global Marketing to regional and local teams , where Legacy brands have been well defined as inline products without any Life Cycle Management plans. Best practice platforms established as digital repositories. Commercial Lead of Corporate Social Responsibility project in Women's health with the objective to develop and provide access in low - low/middle income countries for an innovative drug to prevent post-partum hemoorhage following birth of a child.

Strategic portfolio responsibility and launch excellence to ensure global launch readiness for global product launch in obstetrics. Close alignment of all strategic recommendations with 4 regions across the globe and within local product experts. Evaluations of potential new product opportunities and strategic assessment of innovations and adjacent areas to obstetrics. Close cooperation across functions in Clinical Development and with the regional representatives. Implementation of digital marketing activities as global framework with focus on educational platform.

Development of Global Strategic Plan for the therapeutic area Obstetrics & Gynecology and close cooperation with the regions to ensure implementation and execution. Life Cycle Management plans were developed in collaboration with R&D and leading regional teams. The annual portfolio review process to monitor the R&D project has been supported with business case assessment and ongoing market trend analytics. Business Development projects were identified , assessed , where the acquisition of "Controlled Therapeutics" has been a key achievement to future growth of the therapeutic area. Global Advisory Boards (specific to Women's Health) have been initiated and established as annual clinical and scientific platform to review projects and the overall strategy.

Global Brand Strategy Obstetrics and Reproductive Health, launch plans for new products (Endometrin) and review of new compounds and update of life cycle management plans. Close collaboration with regional teams to ensure implementation and launch plan localizations with strong focus on Asia /Pacific , Middle East and Lama.

Management of outbound Marketing actitivities for the Clinical and Technology Division (Alaris and Pyxis products - Intensive Care infusion technology and pharmaceutical supply). Product strategies and launch plans were implemented where pre-launch activities in the area of Marcom and market research have been integrated.As Business Development Director the strategic plan for 6 countries has been been established and endorsed from management. The potential acquisition targets for Critical Care was identified and multiple projects have been analyzed. Lead for an acquisition project for i.v. pumps including due diligence .

Global Marketing Head for Medical Devices in enteral nutrition (feeding pumps and disposables) Global Marketing for Medical Devices and Pediatrics - pediatric portfolio with oral supplements, enteral tubefeeding products and devices key focus on establishing the global strategy as platform for local execution prepare major international product launches with Marketing planning and product training activities

Strategic consulting role with focus on international healthcare companies , where Finance and Commercial restructuring programs have been successfully implemented. Business planning processes with crossfunctional plans for commercial functions and gates to manufacturing and R&D were updated. Acquisition and liaison activities where the consulting portfolio has been presented.

- Scientific affairs for diagnostics (blood grouping, HLA typing and infectious diseases)- European Marketing for diagnostics and establishing distributor network- Business Unit Head for diagnostics and CEO for diagnostics business (1 year in the US)- business development project for Hemocare division